MedTrace Logo

Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality

NCT05095155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-03-14

No results posted yet for this study

Summary

To search for a genetic marker of B-cell leukemias and lymphomas in children of Kazakh nationality, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with B-cell leukemias and lymphomas in children of Kazakh nationality and normal control will be performed.

Conditions

Interventions

GENETIC

SNP analysis of the DNA

SNP analysis of the DNA obtained from peripheral blood sample

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Principal Investigators

  • Riza Boranbayeva, PhD · JSC "Scientific Center of Pediatrics and Pediatric Surgery"

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-01-20
Completion
2023-01-20

Countries

  • Kazakhstan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05095155 on ClinicalTrials.gov